7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine
|
|
7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine Eigenschaften
- Siedepunkt:
- 598.6±60.0 °C(Predicted)
- Dichte
- 1.83±0.1 g/cm3(Predicted)
- pka
- 13.39±0.70(Predicted)
Sicherheit
7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine Chemische Eigenschaften,Einsatz,Produktion Methoden
7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 4)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
NewCan Biotech Limited | +86-0571-86912261 +8613735419629 |
sales@newcanbio.com | China | 9981 | 58 |
TargetMol Chemicals Inc. | |
support@targetmol.com | United States | 38631 | 58 |
Zhengzhou Granlen Sciences, ltd. | 0371-85513397 +86-18610099868; |
info@granlen.com | China | 1841 | 58 |
TargetMol Chemicals Inc. | 15002134094 |
marketing@targetmol.cn | China | 19704 | 58 |
- 7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)guanine
- 7-(Buten-2-yl)-7,8-dihydro-8-oxo-9-(b-D-xylofuranosyl)guanine
- TLR7agonist10
- 2389988-34-3